7 Links Between Menopause and Psoriasis Flares That Dermatologists Underexplain
The number of women who describe standing in front of a mirror watching plaques reappear — after a decade of clear skin — and having their dermatologist just reach for a stronger topical, with no mention of hormones, is genuinely frustrating. If your psoriasis came back around the time your periods started changing, that timing is not a coincidence. It deserves to be treated as a whole-body conversation, not a skin-only problem.
Learn more about Rose →Estrogen Directly Suppresses the Inflammatory Cytokines That Drive Psoriasis
Psoriasis is fundamentally driven by an overactivation of Th17 immune cells, which flood the skin with pro-inflammatory cytokines — particularly IL-17 and IL-22 — triggering the rapid, abnormal skin cell turnover that creates plaques. Estrogen, specifically 17-beta estradiol, has well-documented inhibitory effects on Th17 cell differentiation and reduces circulating levels of TNF-alpha and IL-6, two other key inflammatory mediators in psoriasis pathology. When estradiol levels begin their erratic decline in perimenopause, this immunological dampening effect weakens, and the Th17 pathway can become significantly more active.
The Skin Barrier Itself Deteriorates as Estrogen Falls
Estrogen stimulates the production of collagen, hyaluronic acid, and sebum — all structural components that keep the skin barrier intact and resilient. A compromised barrier is a known trigger for psoriasis flares because environmental antigens and microbes that would normally be locked out can penetrate and activate the immune response in the dermis. Perimenopausal women often notice that their skin becomes drier and more reactive at the same time their psoriasis worsens, and these two changes share the same root cause.
Cortisol Surges From Poor Sleep Create a Second Inflammatory Hit
Sleep disruption is one of the most consistent and debilitating features of perimenopause, driven by night sweats, hot flashes, and the direct effect of low progesterone on sleep architecture. Chronic fragmented sleep elevates cortisol, and while short-term cortisol is anti-inflammatory, chronically elevated cortisol paradoxically upregulates the very cytokine pathways — particularly TNF-alpha — that worsen psoriasis. Women managing a psoriasis flare should understand that addressing sleep is not just a wellbeing issue; it is a direct intervention in their skin disease.
Weight Gain Around the Midline Amplifies Systemic Inflammation
The hormonal shifts of menopause, particularly the drop in estrogen relative to androgens, promote redistribution of fat to the abdomen even in women whose weight stays stable. Visceral adipose tissue is metabolically active in a problematic way — it secretes adipokines including leptin and resistin, which directly stimulate the Th17 pathway and increase systemic inflammatory load. Since psoriasis severity is already strongly correlated with BMI and visceral fat, this menopausal fat redistribution can be a significant and underappreciated driver of worsening disease.
Estrogen Withdrawal Triggers Mast Cell Hyperactivity in Skin
Mast cells in skin tissue carry estrogen receptors, and falling estrogen levels cause these cells to become more reactive and to degranulate more readily, releasing histamine and other pro-inflammatory compounds. In psoriasis-prone skin, this increased mast cell activity contributes to itch amplification and can initiate the Koebner phenomenon — where scratching or skin trauma triggers new plaques at the site of injury. This partly explains why perimenopausal women often notice their psoriasis becomes itchier even before plaques visibly expand.
The Gut Microbiome Shifts at Menopause, and Psoriasis Notices
Estrogen influences the diversity and composition of the gut microbiome through estrogen receptors on intestinal epithelial cells and by modulating bile acid metabolism; as estrogen falls, microbiome diversity tends to decrease in a pattern associated with increased intestinal permeability. Increased gut permeability — sometimes called leaky gut — allows bacterial endotoxins like lipopolysaccharide (LPS) to enter systemic circulation, which activates innate immune pathways that overlap with psoriatic inflammation. This gut-skin connection is an emerging research area, but the evidence tying menopausal microbiome shifts to inflammatory skin disease is growing steadily.
Hormone Therapy Has Documented but Nuanced Effects on Psoriasis Outcomes
Several observational studies have found that women using menopausal hormone therapy (MHT) report less severe psoriasis and fewer flares compared to untreated peers, which is biologically coherent given estrogen's anti-inflammatory role outlined above. However, the picture is not straightforward — some women report initial worsening on starting MHT, and the route of administration, the type of progestogen used, and individual immune profiles all appear to matter in ways that have not yet been systematically studied in large trials. Women with psoriasis considering MHT should specifically raise their skin disease with their prescriber, as it is a relevant factor in discussing the most appropriate formulation and delivery method.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.